EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Licensing effects of inflammatory factors and TLR ligands on the regenerative capacity of adipose-derived mesenchymal stem cells

Diána Szűcs, Tamás Monostori, Vanda Miklós, Zoltán G Páhi, Szilárd Póliska, Lajos Kemény, Zoltán Veréb

Frontiers in Cell and Developmental Biology · 28.03.2024 · 12

DOI: 10.3389/fcell.2024.1367242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 28.03.2024. Verfasst von Diána Szűcs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine and Cellular Pharmacology Laboratory, Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Adipose tissue-derived mesenchymal stem cells are promising contributors to regenerative medicine, exhibiting the ability to regenerate tissues and modulate the immune system, which is particularly beneficial for addressing chronic inflammatory ulcers and wounds. Despite their inherent capabilities, research suggests that pretreatment amplifies therapeutic effectiveness.

Methods

Our experimental design exposed adipose-derived mesenchymal stem cells to six inflammatory factors for 24 h. We subsequently evaluated gene expression and proteome profile alterations and observed the wound closure rate post-treatment.

Results

Specific pretreatments, such as IL‐1β, notably demonstrated an accelerated wound‐healing process. Analysis of gene and protein expression profiles revealed alterations in pathways associated with tissue regeneration.

Discussion

This suggests that licensed cells exhibit potentially higher therapeutic efficiency than untreated cells, shedding light on optimizing regenerative strategies using adipose tissue-derived stem cells.

Schlagwörter

Stichwörter der Autor:innen

adipose-derived mesenchymal stem cellsimmune systeminflammationlicensingregenerative medicine

Autor:innen und Institutionen

  • Regenerative Medicine and Cellular Pharmacology Laboratory, Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
  • Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.
  • Centre of Excellence for Interdisciplinary Research, Development and Innovation, University of Szeged, Szeged, Hungary.
  • Biobank, University of Szeged, Szeged, Hungary.
  • Genome Integrity and DNA Repair Core Group, Hungarian Centre of Excellence for Molecular Medicine (HCEMM), University of Szeged, Szeged, Hungary.
  • Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.

Zitieren

APA

Szűcs, D., Monostori, T., Miklós, V., Páhi, Z. G., Póliska, S., Kemény, L., & Veréb, Z. (2024). Licensing effects of inflammatory factors and TLR ligands on the regenerative capacity of adipose-derived mesenchymal stem cells. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1367242

Vancouver

Szűcs D, Monostori T, Miklós V, Páhi ZG, Póliska S, Kemény L, et al. Licensing effects of inflammatory factors and TLR ligands on the regenerative capacity of adipose-derived mesenchymal stem cells. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1367242

BibTeX
@article{Szcs2024,
  author = {Szűcs, Diána and Monostori, Tamás and Miklós, Vanda and Páhi, Zoltán G and Póliska, Szilárd and Kemény, Lajos and Veréb, Zoltán},
  title = {Licensing effects of inflammatory factors and TLR ligands on the regenerative capacity of adipose-derived mesenchymal stem cells},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1367242}
}
Kostenlos starten →